September 12, 2020 Comments Off on Patent delisted for Acorda drug AMPYRA Posted in: Uncategorized
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
September 12, 2020 Comments Off on Patent delisted for Astrazeneca Ab drug BYDUREON PEN Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appear…
